Wedbush Securities Inc. Has $632,000 Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Wedbush Securities Inc. increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.4% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 2,148 shares of the biotechnology company’s stock after purchasing an additional 51 shares during the quarter. Wedbush Securities Inc.’s holdings in Axon Enterprise were worth $632,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Prudential PLC lifted its stake in Axon Enterprise by 9.3% in the second quarter. Prudential PLC now owns 33,304 shares of the biotechnology company’s stock valued at $9,799,000 after acquiring an additional 2,838 shares during the last quarter. PFG Investments LLC raised its holdings in shares of Axon Enterprise by 2.2% in the 2nd quarter. PFG Investments LLC now owns 3,847 shares of the biotechnology company’s stock valued at $1,132,000 after purchasing an additional 82 shares during the period. Quest Partners LLC lifted its stake in Axon Enterprise by 98,200.0% in the 2nd quarter. Quest Partners LLC now owns 983 shares of the biotechnology company’s stock valued at $289,000 after purchasing an additional 982 shares during the last quarter. Emerald Advisers LLC bought a new position in Axon Enterprise during the second quarter worth about $267,000. Finally, Acadian Asset Management LLC increased its position in Axon Enterprise by 372.6% during the second quarter. Acadian Asset Management LLC now owns 32,323 shares of the biotechnology company’s stock worth $9,502,000 after buying an additional 25,484 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Trading Up 6.3 %

Shares of AXON stock opened at $384.51 on Friday. The stock has a 50 day simple moving average of $337.29 and a 200 day simple moving average of $313.60. Axon Enterprise, Inc. has a 1 year low of $189.12 and a 1 year high of $384.73. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The stock has a market cap of $29.02 billion, a P/E ratio of 112.43, a price-to-earnings-growth ratio of 9.50 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.18. The company had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. Axon Enterprise’s quarterly revenue was up 34.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.80 EPS. On average, research analysts predict that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of recent analyst reports. JMP Securities raised their price objective on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday. Jefferies Financial Group began coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price objective for the company. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price objective on shares of Axon Enterprise in a research report on Wednesday, August 7th. Bank of America assumed coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $380.00 target price for the company. Finally, Robert W. Baird increased their price target on shares of Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a report on Tuesday. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $365.38.

Insider Buying and Selling at Axon Enterprise

In other news, CFO Brittany Bagley sold 4,338 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the sale, the chief financial officer now owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Axon Enterprise news, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the transaction, the chief financial officer now directly owns 98,825 shares in the company, valued at $37,449,733.75. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total value of $318,177.00. Following the sale, the director now owns 3,653 shares of the company’s stock, valued at $1,291,445.09. The disclosure for this sale can be found here. Insiders have sold a total of 316,981 shares of company stock valued at $115,281,744 in the last ninety days. 6.10% of the stock is currently owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.